Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12565534 | Nano-antibody targeting CAIX antigen and application thereof | 🖼🧊📄§ | 2026-03-03 | 2040-08-25 | 0 | 31 |
| 12565537 | Compositions and methods targeting the nucleotide free state of RAS to block oncogenic signaling and transformation | 🖼🧊📄§ | 2026-03-03 | 2040-06-18 | 0 | 31 |
| 12565642 | Engineered DNASE enzymes for thrombosis therapy | 🖼🧊📄§ | 2026-03-03 | 2043-10-30 | 0 | 31 |
| 12565643 | Alpha-galactosidase protein for enzyme replacement therapy (ERT) and methods of use | 🖼🧊📄§ | 2026-03-03 | 2040-09-18 | 0 | 31 |
| 12564601 | Methods for treating hepatitis B infection | 🖼🧊📄§ | 2026-03-03 | 2042-02-02 | 0 | 31 |
| 12564829 | Biologically applicable water-soluble heterogeneous catalysts for para-hydrogen induced polarization | 🖼🧊📄§ | 2026-03-03 | 2042-03-14 | 0 | 31 |
| 12564822 | Device for manufacture of T-cells for autologous cell therapy | 🖼🧊📄§ | 2026-03-03 | 2042-03-02 | 0 | 31 |
| 12564547 | Compositions, formulations, and methods for skin treatment | 🖼🧊📄§ | 2026-03-03 | 2043-01-06 | 0 | 31 |
| 12564548 | Bake type makeup cosmetic composition and method for producing same | 🖼🧊📄§ | 2026-03-03 | 2041-02-25 | 0 | 31 |
| 12564551 | Composition or oat extract comprising avenanthramide and β-glucan | 🖼🧊📄§ | 2026-03-03 | 2040-03-06 | 0 | 31 |
| 12564552 | Oral product with a basic amine and an ion pairing agent | 🖼🧊📄§ | 2026-03-03 | 2042-09-29 | 0 | 31 |
| 12564553 | Suspension containing heterocyclidene acetamide derivative | 🖼🧊📄§ | 2026-03-03 | 2042-03-29 | 0 | 31 |
| 12564554 | Co-amorphous forms of beta-lactoglobulin and a drug substance | 🖼🧊📄§ | 2026-03-03 | 2040-12-04 | 0 | 31 |
| 12564555 | Continuous processes for manufacturing impregnated porous carriers and for manufacturing pharmaceuticals containing impregnated porous carriers | 🖼🧊📄§ | 2026-03-03 | 2040-12-15 | 0 | 31 |
| 12564556 | Compositions comprising disodium levofolinate | 🖼🧊📄§ | 2026-03-03 | 2042-12-22 | 0 | 31 |
| 12564558 | Hybrid exosomal-polymeric (hexpo) nano-platform for delivery of RNAi therapeutics | 🖼🧊📄§ | 2026-03-03 | 2037-12-08 | 0 | 31 |
| 12564560 | Selective serotonin receptor modulators and methods of making and using the same | 🖼🧊📄§ | 2026-03-03 | 2045-04-02 | 0 | 31 |
| 12564564 | Composition comprising tyrosol and amino acids and its application in enhancing athletic performance and combating fatigue | 🖼🧊📄§ | 2026-03-03 | 2044-11-24 | 0 | 31 |
| 12564569 | Carboplatin complex and pharmaceutical preparation thereof | 🖼🧊📄§ | 2026-03-03 | 2042-02-25 | 0 | 31 |
| 12564570 | Use of leoligin in the prevention of tissue damage | 🖼🧊📄§ | 2026-03-03 | 2041-08-27 | 0 | 31 |
| 12564571 | Compositions and methods for the treatment of equine protozoal myeloencephalitis | 🖼🧊📄§ | 2026-03-03 | 2039-02-20 | 0 | 31 |
| 12564577 | Nanoliposomes for sustained delivery of tacrolimus for treatment of anterior segment eye diseases | 🖼🧊📄§ | 2026-03-03 | 2043-04-27 | 0 | 31 |
| 12564572 | Topical ocular delivery of cromakalim | 🖼🧊📄§ | 2026-03-03 | 2044-10-04 | 0 | 31 |
| 12564585 | Nutraceuticals having sustained release for improved bioavailability and method of production | 🖼🧊📄§ | 2026-03-03 | 2040-12-18 | 0 | 31 |
| 12564582 | Use of pridopidine for treating dystonias | 🖼🧊📄§ | 2026-03-03 | 2043-10-19 | 0 | 31 |
| 12564592 | Injectable leucovorin formulations and methods of preparing same | 🖼🧊📄§ | 2026-03-03 | 2045-07-14 | 0 | 31 |
| 12564593 | Topical formulation for a JAK inhibitor | 🖼🧊📄§ | 2026-03-03 | 2045-07-18 | 0 | 31 |
| 12564594 | Pharmaceutical composition containing 9-ethyl-6, 6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6, 11-dihydro-5H-benzo[b]carbazole-3-carbonitrile | 🖼🧊📄§ | 2026-03-03 | 2039-06-28 | 0 | 31 |
| 12564598 | Nitric oxide-sensitive hydrogel | 🖼🧊📄§ | 2026-03-03 | 2042-01-10 | 0 | 31 |
| 12564597 | Ibogaine analogs as therapeutics for neurological and psychiatric disorders | 🖼🧊📄§ | 2026-03-03 | 2041-03-04 | 0 | 31 |
| 12564604 | Photosynthetic cellular substances and methods of use thereof | 🖼🧊📄§ | 2026-03-03 | 2042-08-19 | 0 | 31 |
| 12564605 | Plant based compositions and methods for the delivery of magnesium | 🖼🧊📄§ | 2026-03-03 | 2039-08-13 | 0 | 31 |
| 12564606 | Pharmaceutical composition for treating wounds | 🖼🧊📄§ | 2026-03-03 | 2039-11-21 | 0 | 31 |
| 12564607 | Cell population comprising mesenchymal cells, pharmaceutical composition comprising the same, and method for producing the same | 🖼🧊📄§ | 2026-03-03 | 2040-06-12 | 0 | 31 |
| 12564610 | Human periventricular endothelial cell therapy for neuropsychiatric disorders | 🖼🧊📄§ | 2026-03-03 | 2040-10-19 | 0 | 31 |
| 12564615 | Treatment method for cardiac hypertrophy | 🖼🧊📄§ | 2026-03-03 | 2043-12-19 | 0 | 31 |
| 12564611 | Pancreatic endocrine progenitor cells and use thereof | 🖼🧊📄§ | 2026-03-03 | 2040-09-17 | 0 | 31 |
| 12564618 | Antihypertensive peptide probiotic goat milk powder and preparation method thereof | 🖼🧊📄§ | 2026-03-03 | 2045-05-15 | 0 | 31 |
| 12564624 | Ostrich antibody for bacterial infectious diseases | 🖼🧊📄§ | 2026-03-03 | 2044-04-11 | 0 | 31 |
| 12564626 | Serum free intracellular pathogen vaccine | 🖼🧊📄§ | 2026-03-03 | 2039-12-20 | 0 | 31 |
| 12564623 | Methods and compositions for treating cancer | 🖼🧊📄§ | 2026-03-03 | 2038-06-15 | 0 | 31 |
| 12564625 | Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Δ5nsP3 | 🖼🧊📄§ | 2026-03-03 | 2044-05-06 | 0 | 31 |
| 12564632 | Conjugates of biomolecule and use thereof | 🖼🧊📄§ | 2026-03-03 | 2038-11-07 | 0 | 31 |
| 12564633 | Oncolytic virus strain | 🖼🧊📄§ | 2026-03-03 | 2044-05-21 | 0 | 31 |
| 12564637 | Nucleic acid mazzocchio and methods of making and use thereof | 🖼🧊📄§ | 2026-03-03 | 2040-04-09 | 0 | 31 |
| 12564639 | Cationic nanostructures for intra-cartilage delivery of contrast agents and diagnostic uses thereof | 🖼🧊📄§ | 2026-03-03 | 2043-05-01 | 0 | 31 |
| 12564641 | Eribulin antibody-drug conjugates and methods of use | 🖼🧊📄§ | 2026-03-03 | 2042-12-23 | 0 | 31 |
| 12564644 | Cyclodextrin complexes of specialized proresolving mediators | 🖼🧊📄§ | 2026-03-03 | 2043-03-01 | 0 | 31 |
| 12564649 | Interface material for virtual reality interaction and preparation method therefor | 🖼🧊📄§ | 2026-03-03 | 2042-07-29 | 0 | 31 |
| 12564646 | Treatment of age-related cognitive decline using genetically modified viral vectors | 🖼🧊📄§ | 2026-03-03 | 2042-06-15 | 0 | 31 |